Stocksigma LogoStocksigma Logo

Quest Laboratories Reports Nil Deviation in IPO Fund Utilization for H1 FY27

Quest Laboratories Limited reported zero deviation or variation in the utilization of IPO proceeds for the half-year ended 30th Sep'26

Quest Laboratories Reports Nil Deviation in IPO Fund Utilization for H1 FY27

Quest Laboratories Ltd 路 Others (Uncategorized) 路 12 Nov 2026, 3:25 am

Quest Laboratories Reports Nil Deviation in IPO Fund Utilization for H1 FY27 Quest Laboratories Limited reported zero deviation or variation in the utilization of IPO proceeds for the half-year ended 30th Sep'26. The company raised Rs 43.16 crore by issuing 44,49,600 equity shares at Rs 97 per share. Of the total proceeds, Rs 10.26 crore has been utilized toward manufacturing capex against an allocated Rs 26.00 crore, leaving Rs 15.74 crore unutilized. Full allocations of Rs 10.00 crore for working capital and Rs 3.38 crore for general corporate purposes were completely utilized, alongside Rs 3.59 crore in issue expenses.

Original exchange filing (PDF)

More announcements from Quest Laboratories Ltd

All Quest Laboratories Ltd announcements